Bellevue Life Sciences Acquisition (BLAC) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Bellevue Life Sciences Acquisition Corp  (NASDAQ: BLAC)


Bellevue Life Sciences Acquisition's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLAC Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change -69.44 %
Seq. Revenue Change -34.79 %
Revenue In Millions $0.32
Gross Profit Margin 27.44 %
Gross Profit Margin Total Ranking # 2372
Gross Profit In Millions $0.09
Y / Y Gross Profit Change 164.18 %
Seq. Gross Profit Change -45.97 %


Commenting Second Quarter 2026 Gross Profit Margin
Bellevue Life Sciences Acquisition Corp experienced contraction in Gross Profit by -45.97 % to $0 millions and Revenue by -34.79 %, while Gross Profit Margin fell to 27.44 %, above company*s average Gross Profit Margin.


Observing second quarter 2026 results within Medical Equipment & Supplies industry 146 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2372, from total ranking in the previous quarter at 2560.
Learn about Gross Margin
BLAC's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 147
Healthcare Sector # 373
Overall # 2353

Gross Profit Margin Statistics
High Average Low
41.69 % 25.35 % 3.17 %
(Sep 30 2025)   (Jun 30 2025)


BLAC Gross Income Trends • More of BLAC's Profitabilty Ratios • BLAC Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
BLAC's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BLAC's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BLAC's Competitors
Gross Profit Margin Profit Margin for Bellevue Life Sciences Acquisition's Suppliers
Gross Profit Margin Profit Margin for BLAC's Customers

You may also want to know
BLAC's Annual Growth Rates BLAC's Profitability Ratios BLAC's Asset Turnover Ratio BLAC's Dividend Growth
BLAC's Roe BLAC's Valuation Ratios BLAC's Financial Strength Ratios BLAC's Gross Profit Growth
BLAC's Roa BLAC's Inventory Turnover Ratio BLAC's Growth Rates BLAC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Staar Surgical Co  74.55 %$ 69.727  Millions$ 93.535  Millions
Orthopediatrics Corp  74.27 %$ 52.366  Millions$ 70.508  Millions
Iradimed Corporation  74.07 %$ 15.160  Millions$ 20.466  Millions
Cytosorbents Corporation  73.18 %$ 7.049  Millions$ 9.633  Millions
Nexalin Technology Inc   73.16 %$ 0.009  Millions$ 0.012  Millions
Myomo Inc   73.07 %$ 8.852  Millions$ 12.114  Millions
Irhythm Holdings Inc   72.80 %$ 163.205  Millions$ 224.172  Millions
Co diagnostics Inc   72.73 %$ 0.121  Millions$ 0.166  Millions
Axogen inc   72.67 %$ 50.674  Millions$ 69.731  Millions
Omada Health Inc   72.62 %$ 63.787  Millions$ 87.835  Millions
Tela Bio Inc   72.28 %$ 13.943  Millions$ 19.291  Millions
Alphatec Holdings Inc   72.17 %$ 154.098  Millions$ 213.513  Millions
Lemaitre Vascular Inc   72.13 %$ 50.764  Millions$ 70.382  Millions
Align Technology inc   71.71 %$ 757.430  Millions$ 1,056.192  Millions
Orchestra Biomed Holdings Inc   71.59 %$ 0.063  Millions$ 0.088  Millions
Orthofix Medical Inc   70.97 %$ 149.707  Millions$ 210.933  Millions
Zimmer Biomet Holdings Inc   70.81 %$ 1,541.500  Millions$ 2,177.000  Millions
Logicmark Inc  70.71 %$ 2.368  Millions$ 3.349  Millions
Boston Scientific Corporation  70.71 %$ 3,848.000  Millions$ 5,442.000  Millions
Establishment Labs Holdings Inc   70.64 %$ 47.711  Millions$ 67.542  Millions
Intuitive Surgical Inc   70.45 %$ 2,222.200  Millions$ 3,154.100  Millions
Insulet Corporation  70.18 %$ 562.600  Millions$ 801.700  Millions
Livanova Plc  70.07 %$ 273.670  Millions$ 390.587  Millions
Qhslab Inc   69.59 %$ 0.590  Millions$ 0.847  Millions
Globus Medical Inc   69.42 %$ 548.173  Millions$ 789.612  Millions
Bioventus Inc   68.97 %$ 105.666  Millions$ 153.208  Millions
Mimedx Group Inc   68.96 %$ 44.381  Millions$ 64.362  Millions
Skinhealth Systems Inc   68.42 %$ 49.338  Millions$ 72.113  Millions
Genedx Holdings Corp   68.37 %$ 78.238  Millions$ 114.440  Millions
Stryker Corp  68.27 %$ 4,498.000  Millions$ 6,589.000  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.